MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis

Acta Neuropathol. 2021 Jan;141(1):127-131. doi: 10.1007/s00401-020-02236-5. Epub 2020 Oct 19.

¹ Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. brigitte.wildemann@med.uni-heidelberg.de.
² Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
³ Institute of Neuropathology, University Medical Center Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.
⁴ Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
⁵ Clinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

No abstract available

Keywords: Antibodies; Myelin oligodendrocyte glycoprotein (MOG); Optic neuritis; Ovarian teratoma.

Publication types